确定性放疗后挽救性切除在非小细胞肺癌中的作用
该研究基于美国国家癌症数据库2004至2020年数据,评估确定性放疗后延长延迟(>180天)行挽救性切除的293例非小细胞肺癌患者的围手术期结局与5年总生存。结果显示围手术期结局可接受,pN0、pN1、pN2患者5年总生存分别为38.6%、43.3%、24.0%。
要点
- 确定性放疗后>180天行挽救性切除的患者中,肺叶切除占64.5%,全肺切除占17.1%,楔形切除占7.5%。
- 楔形切除、肺叶切除、全肺切除的30天死亡率分别为0%、3.4%、6.4%,90天死亡率分别为0%、6.2%、12.8%。
- pN0、pN1、pN2患者5年总生存分别为38.6%、43.3%、24.0%。
核心结论
- 在这项全国性分析中,确定性放疗后延长延迟至切除与高度选择患者队列中可接受的围手术期结局相关。
研究设计与样本
- 基于美国国家癌症数据库2004至2020年的数据分析,纳入确定性放疗(包括总剂量>60 Gy的外照射治疗)开始后>180天行切除的非小细胞肺癌患者,共293例。
- 按手术方式和病理淋巴结状态进行亚组分析。
主要发现
- 临床分期分布:I至II期53例(18.1%),IIIA期111例(37.9%),IIIB期106例(36.2%),IIIC期13例(4.4%),IV期10例(3.4%)。
- 放疗剂量中位数为64.8 Gy(四分位距60.0-66.6 Gy),从放疗至切除的中位天数为221.0天(四分位距193.0-287.0天)。
- 手术方式:肺叶切除64.5%,全肺切除17.1%,楔形切除7.5%。
- 楔形切除、肺叶切除、全肺切除的30天再入院率分别为4.8%、4.8%、8.3%,30天死亡率分别为0%、3.4%、6.4%,90天死亡率分别为0%、6.2%、12.8%。
- pN0、pN1、pN2患者5年总生存分别为38.6%(95% CI 30.0-47.2)、43.3%(95% CI 16.3-67.9)、24.0%(95% CI 9.8-41.7)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: This study evaluated outcomes of patients who undergo extended delay to resection after definitive radiation therapy for non-small cell lung cancer (NSCLC). METHODS: Perioperative outcomes and 5-year overall survival of patients with NSCLC who underwent definitive radiation therapy, followed by resection, from 2004 to 2020 in the National Cancer Database were evaluated. Patients who underwent resection >180 days after the initiation of radiation therapy (including any external beam therapy at a total dose of >60 Gy) were included in the analysis. Subgroup analyses were conducted by operation type and pathologic nodal status. RESULTS: From 2004 to 2020, 293 patients had an extended delay to resection after definitive radiation therapy. The clinical stage distribution was stage I to II in 53 patients (18.1%), stage IIIA in 111 (37.9%), stage IIIB in 106 (36.2%), stage IIIC in 13 (4.4%), and stage IV in 10 (3.4%). Median dose of radiation therapy received was 64.8 Gy (interquartile range, 60.0-66.6 Gy). Median days from radiation therapy to resection were 221.0 (interquartile range, 193.0-287.0) days. Lobectomy (64.5%) was the most common operation, followed by pneumonectomy (17.1%) and wedge resection (7.5%). For wedge resection, lobectomy, and pneumonectomy, the 30-day readmission rate was 4.8%, 4.8%, and 8.3%, the 30-day mortality rate was 0%, 3.4%, and 6.4%, and the 90-day mortality rate was 0%, 6.2%, and 12.8%, respectively. Overall survival at 5 years for patients with pN0, pN1, and pN2 disease was 38.6% (95% CI, 30.0-47.2), 43.3% (95% CI, 16.3-67.9), and 24.0% (95% CI, 9.8-41.7), respectively. CONCLUSIONS: In this national analysis, extended delay to resection after definitive radiation therapy was associated with acceptable perioperative outcomes among a highly selected patient cohort.
引用
- Rosenstein AL, Potter AL, Senthil P, et al. The Role of Salvage Resection After Definitive Radiation Therapy for Non-small Cell Lung Cancer. Ann Thorac Surg. 2023. PMID: 37544397. doi:10.1016/j.athoracsur.2023.07.035
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。